BEIER, NORBERT,SCHOLZ, WOLFGANG,BETZ, ULRICH,BRAENDLE, MARIAN
申请号：
DK09741802
公开号：
DK2271327T3
申请日:
2009.04.11
申请国别(地区):
DK
年份:
2015
代理人:
摘要：
The invention relates to a pharmaceutical composition comprising as active ingredient an effective amount of 2-Methyl-4,5-di-(methylsulfonyl)-benzoyl-guanidine, or derivatives thereof, for the prophylaxis and therapy of Type II diabetes mellitus, the Metabolic syndrome, diabetic nephropathy and/or neuropathy. Another object of the invention concerns the use of 2-Methyl-4,5-di-(methylsulfonyl)-benzoyl-guanidine, or derivatives thereof, for the enhancement of insulin sensitivity and the preservation or increase of ß-cell compensation.
